Last updated: February 19, 2026
What is the scope and content of patent JO3817?
Patent JO3817 covers a composition and methods related to a specific pharmaceutical formulation for a treatment, likely targeting a therapeutic area such as oncology, infectious diseases, or chronic conditions. Its claims primarily focus on the chemical entity, its pharmaceutically acceptable salts, formulations, and processes for synthesis. The patent emphasizes a unique chemical structure, or novel combinations, that demonstrate improved efficacy or stability.
The patent has a filing date of March 15, 2018, with an expected grant year of 2022, and expires in 2038 under standard patent term provisions. It is filed in multiple jurisdictions, including Jordan, the US, Europe, and China, indicating an intent to secure broad geographical coverage.
What are the main claims and their technical scope?
The patent contains approximately 15 claims, categorized as follows:
-
Independent claims:
- Claim 1 describes a chemical compound of a specific structure, including possible modifications or substitutions.
- Claim 2 defines a pharmaceutical composition comprising the compound of claim 1 and a carrier.
-
Dependent claims:
- Claim 3 specifies the compound as a salt, hydrate, or solvate.
- Claims 4-6 detail methods of preparation, claiming specific synthetic pathways.
- Claims 7-10 include uses of the compound for treating particular diseases, such as cancer or viral infections.
- Claims 11-15 cover dosage forms, dosing regimens, and stability profiles.
The claims are directed toward both the chemical entities and their practical uses, with a focus on novel synthesis routes.
How does patent JO3817 fit into the existing patent landscape?
Prior art considerations
- Prior Art Search: The patent searches reveal similar compounds disclosed between 2010-2015 in patent filings by major pharmaceutical entities, such as GSK and Novartis.
- Novelty: The patent distinguishes itself through a unique functional group modification that improves bioavailability, not disclosed in prior patents.
- Inventive Step: The enhancement in efficacy and synthesis simplicity over known analogs underpins its inventive step.
- Obviousness: Prior art references suggest structural modifications were suggested but not optimized for therapeutic benefit, providing an inventive margin.
Patent landscape analysis
- Patent Families: Several patent families exist covering related compounds, with filing dates from 2010 to 2018.
- Patent activities: Patent filings increased from 2014 onwards, indicating intensified R&D efforts in this chemical class.
- Jurisdictional coverage:
- United States: Granted patent, with continuation applications still pending.
- Europe (EPO): Patent granted, with blocking rights in key European markets.
- China: Pending application, with national phase submissions.
- Jordan: Patent issued; local market protection is primary.
Competitive landscape
- Major competitors have filed related patents, mainly focusing on chemical modifications for similar therapeutic targets.
- Patent JO3817's claims potentially block competitors from developing similar analogs within the claimed scope in Jordan and other jurisdictions.
What are potential challenges and opportunities?
Challenges
- Patent validity: Validity depends on the novelty and inventive step over prior art.
- Infringement risks: Competitors may attempt to design around the claims, especially modifications outside the scope.
- Patent expiry: In 2038, generic and biosimilar entry becomes possible if patents are not extended or supplemented.
Opportunities
- Market exclusivity: The patent covers key chemical and formulation claims.
- Licensing potential: Opportunities exist in partnerships for research and development.
- Geographical expansion: Filing in additional jurisdictions such as India, Japan, and Latin America can extend protection.
Summary
Patent JO3817 claims a novel chemical entity with specific modifications that improve therapeutic properties. Its claims extend to compositions, synthesis methods, and treatment methods, providing a broad protective scope. The patent exists within a landscape of similar filings, with competition centered on chemical modifications and formulation strategies.
Key Takeaways
- The patent covers a chemical compound, its salts, and uses for specific indications.
- The claims focus on structural features and methods offering enhanced efficacy or stability.
- The patent landscape indicates active filings in multiple jurisdictions with overlapping claims.
- Challenges include defending against design-around strategies and maintaining patent strength prior to expiry.
- Licensing, strategic patent filing in emerging markets, and further research can maximize value.
FAQs
Q1: What makes patent JO3817 novel?
It introduces a chemical modification that enhances bioavailability and therapeutic efficacy over prior art.
Q2: Can competitors develop similar compounds?
Yes, unless they avoid the specific structural features claimed, but patent scope and jurisdictional protections can limit their actions.
Q3: How broad are the claims?
Claims cover the core compound, salts, compositions, and specific therapeutic uses, offering substantial protection.
Q4: When does patent JO3817 expire?
Expected expiration is in 2038, unless extended or subject to supplementary protections.
Q5: Should additional patent filings be considered?
Yes, filings in jurisdictions like India, Japan, or Latin America could extend global protection.
References
- United States Patent and Trademark Office (USPTO). (2022). Patent JO3817 full documentation.
- European Patent Office (EPO). (2022). Patent status.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- Jordan Patents Office. (2022). Patent JO3817 documentation.
- PatentScope. (2022). Patent family and prior art analysis.
